ConductScience.org, home

Paper390559

Ribavirin: an antiviral agent.

Sidwell RW and 2 others. Pharmacol Ther, 1979. Cited by 117 papers, by iCite.

Cite this record

ConductScience Library. Ribavirin: an antiviral agent. Papers, record 390559. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/390559

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Ribavirin: an antiviral agent.
PubMed
Journal
Pharmacol Ther
PubMed
Year
1979
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
117
iCite
Relative citation ratio, by iCite
3.31
iCite
Revised in PubMed
2019-09-11
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sidwell RWR W
2Robins RKR K
3Hillyard IWI W

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antiviral AgentsMajor topic
RibavirinMajor topic
RibonucleosidesMajor topic
Animals
Antineoplastic Agents
Autoimmune Diseases
Bacteria
Hepatitis
Humans
Immunosuppressive Agents
Plant Viruses

Source PubMed

Download CSV of topics

Cited by27

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 117 citations.

PMIDTitleJournalYearIn PapersSource
40718474Screening and Identification of Multiple Peptides Homologous to the Fusion Glycoprotein Gc of Schmallenberg Virus Able to Inhibit Viral Infection.Transbound Emerg Dis2025https://conductscience.org/library/papers/40718474PubMed
40519175Bandavirus dabieense: A review of epidemiology, clinical characteristics, pathophysiology, treatment and prevention.Virulence2025https://conductscience.org/library/papers/40519175PubMed
40050867Antiviral treatment for viral pneumonia: current drugs and natural compounds.Virol J2025https://conductscience.org/library/papers/40050867PubMed
37250214New 1,3,4-thiadiazoles as potential anticancer agents: pro-apoptotic, cell cycle arrest, molecular modelling, and ADMET profile.RSC Adv2023https://conductscience.org/library/papers/37250214PubMed
36851554Biochemistry of the Respiratory Syncytial Virus L Protein Embedding RNA Polymerase and Capping Activities.Viruses2023https://conductscience.org/library/papers/36851554PubMed
36766795Immunomodulation of Natural Killer Cell Function by Ribavirin Involves TYK-2 Activation and Subsequent Increased IFN-γ Secretion in the Context of In Vitro Hepatitis E Virus Infection.Cells2023https://conductscience.org/library/papers/36766795PubMed
36464706Small molecules in the treatment of COVID-19.Signal Transduct Target Ther2022https://conductscience.org/library/papers/36464706PubMed
32571182Molecular Targets in the Chemotherapy of Coronavirus Infection.Biochemistry (Mosc)2020https://conductscience.org/library/papers/32571182PubMed
32287578Chapter 3 Antiviral drugs: general considerations.Perspect Med Virol1985https://conductscience.org/library/papers/32287578PubMed
31641088Attenuation of Live-Attenuated Yellow Fever 17D Vaccine Virus Is Localized to a High-Fidelity Replication Complex.mBio2019https://conductscience.org/library/papers/31641088PubMed
27152039Clinical presentation and management of suspected ribavirin toxicosis in a dog.Can Vet J2016https://conductscience.org/library/papers/27152039PubMed
21989310Pharmacological and biological antiviral therapeutics for cardiac coxsackievirus infections.Molecules2011https://conductscience.org/library/papers/21989310PubMed
21058912Review of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for Lassa fever.Clin Infect Dis2010https://conductscience.org/library/papers/21058912PubMed
18822145Neuraminidase activity provides a practical read-out for a high throughput influenza antiviral screening assay.Virol J2008https://conductscience.org/library/papers/18822145PubMed
16043507Ribavirin is not a functional mimic of the 7-methyl guanosine mRNA cap.RNA2005https://conductscience.org/library/papers/16043507PubMed
15733013Peginterferon alpha-2a (40KD) plus ribavirin: a review of its use in the management of patients with chronic hepatitis C and persistently 'normal' ALT levels.Drugs2005https://conductscience.org/library/papers/15733013PubMed
12656650Peginterferon-alpha-2a (40kD) plus ribavirin: a review of its use in the management of chronic hepatitis C.Drugs2003https://conductscience.org/library/papers/12656650PubMed
11827565Interferon-alpha-2b plus ribavirin: a review of its use in the management of chronic hepatitis C.Drugs2002https://conductscience.org/library/papers/11827565PubMed
10792198The single dose pharmacokinetics of ribavirin in subjects with chronic liver disease.Br J Clin Pharmacol2000https://conductscience.org/library/papers/10792198PubMed
7533301Picornavirus inhibitors.Pharmacol Ther1994https://conductscience.org/library/papers/7533301PubMed

See all 27 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/390559

GET https://conductscience.org/api/papers/v1/390559/cited_by?page=2